Clinical Research Site

Hialeah, Florida 33016

3 studies enrolling now · 12 studies all time

What they study most

Agitation, Agitation in Patients With Dementia of the Alzheimer's Type, Agitation, Psychomotor, Agitation,Psychomotor, Alzheimer Disease, Binge-Eating Disorder, Depression, Excessive Sleepiness, Major Depressive Disorder, Migraine, Scabies, Shift-work Disorder

Studies at this site

• Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study — Stopped early
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder — Enrolling by invitation
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed